| Entry |
| ||||||
|---|---|---|---|---|---|---|---|
| Name | Treprostinil monosodium salt; Treprostinil sodium; Trepulmix (TN) | ||||||
| Formula | C23H33O5. Na | ||||||
| Exact mass | 412.2226 | ||||||
| Mol weight | 412.4949 | ||||||
| Structure |  | ||||||
| Simcomp | |||||||
| Class | Blood modifier agent DG01950 Antithrombotic agent DG01712 Antiplatelet agent Hormonal agent DG01961 Prostaglandin derivative DG01810 Prostacycline derivative Metabolizing enzyme substrate DG02918 CYP2C8 substrate | ||||||
| Remark |
| ||||||
| Efficacy | Anticoagulant, Vasodilator, Platelet aggregation inhibitor, Prostaglandin I2 receptor agonist | ||||||
| Comment | Prostacycline derivative | ||||||
| Target | PTGIR [HSA:5739] [KO:K04263] | ||||||
| Pathway |
| ||||||
| Metabolism | Enzyme: CYP2C8 [HSA:1558] | ||||||
| Interaction | |||||||
| Structure map |
| ||||||
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] B BLOOD AND BLOOD FORMING ORGANS B01 ANTITHROMBOTIC AGENTS B01A ANTITHROMBOTIC AGENTS B01AC Platelet aggregation inhibitors excl. heparin B01AC21 Treprostinil D08628 Treprostinil monosodium salt Drug groups [BR:br08330] Blood modifier agent DG01950 Antithrombotic agent DG01712 Antiplatelet agent DG00161 Treprostinil D08628 Treprostinil monosodium salt Hormonal agent DG01961 Prostaglandin derivative DG01810 Prostacycline derivative DG00161 Treprostinil D08628 Treprostinil monosodium salt Metabolizing enzyme substrate DG02918 CYP2C8 substrate DG00161 Treprostinil D08628 Treprostinil monosodium salt Target-based classification of drugs [BR:br08310] G Protein-coupled receptors Rhodopsin family Prostacyclin PTGIR D08628 Treprostinil monosodium salt New drug approvals in Europe [br08329.html] European public assessment reports (EPAR) authorised medicine D08628 New drug approvals in the USA, Europe and Japan [br08328.html] Approval dates by FDA, EMA and PMDA D08628 Drug metabolizing enzymes and transporters [br08309.html] Drug metabolizing enzymes D08628 Drug groups [BR:br08330] Blood modifier agent DG01950 Antithrombotic agent DG01712 Antiplatelet agent DG00161 Treprostinil Hormonal agent DG01961 Prostaglandin derivative DG01810 Prostacycline derivative DG00161 Treprostinil Metabolizing enzyme substrate DG02918 CYP2C8 substrate DG00161 Treprostinil | ||||||
| Other DBs |
| ||||||
| KCF data | ATOM 29 1 Z Na 7.3420 -18.7457 #+ 2 C1x C 11.0600 -21.6300 3 C1y C 11.8300 -22.8900 4 C1y C 13.1600 -22.4000 5 C1y C 13.1600 -21.0000 6 C1y C 11.8300 -20.5100 7 C1b C 14.3500 -23.1700 8 C1b C 15.5400 -22.4000 9 C1c C 16.7300 -23.1700 10 C1b C 17.9200 -22.4000 11 O1a O 16.7300 -24.5700 12 C1b C 19.1800 -23.1700 13 C1b C 20.3700 -22.4000 14 C1b C 21.5600 -23.1700 15 C1a C 22.7500 -22.4000 16 O1a O 11.3400 -24.2200 17 C1x C 14.2100 -20.0900 18 C8y C 14.0000 -18.6900 19 C8y C 12.6700 -18.2000 20 C1x C 11.6200 -19.1100 21 C8x C 15.0500 -17.8500 22 C8x C 14.8400 -16.4500 23 C8x C 13.5100 -15.9600 24 C8y C 12.4600 -16.8700 25 O2a O 11.2700 -16.1700 26 C1b C 10.0800 -16.8700 27 C6a C 8.8900 -16.1700 28 O6a O 7.6300 -16.8700 #- 29 O6a O 8.8900 -14.7700 BOND 30 1 2 3 1 2 3 4 1 3 4 5 1 4 5 6 1 5 2 6 1 6 4 7 1 #Up 7 7 8 1 8 8 9 1 9 9 10 1 10 9 11 1 #Down 11 10 12 1 12 12 13 1 13 13 14 1 14 14 15 1 15 3 16 1 #Down 16 5 17 1 #Down 17 17 18 1 18 18 19 1 19 19 20 1 20 6 20 1 #Down 21 18 21 2 22 21 22 1 23 22 23 2 24 23 24 1 25 19 24 2 26 25 24 1 27 25 26 1 28 26 27 1 29 27 28 1 30 27 29 2 |